Atlas company financials

ABBOTT LABORATORIES

Standardized 19-year financial series for ABBOTT LABORATORIES, built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.

United StatesCIK 0000001800FY2007 → FY2025

Open JSON Download CSV Download XLSX Quarterly JSON Summary JSON Filing index

Latest fiscal year

FY2025

Revenue

$44.3B

Adjusted EBITDA

—

Net result

$6.5B

Net financial debt

$4.4B

Latest source: FY2025 filing · published data snapshot generated April 26, 2026

Phase 2 summary

Latest quarter, TTM, and growth are now pre-computed for chat and templates.

Latest quarter revenue

$11.4B

TTM revenue

$43.5B

TTM free cash flow

—

Latest quarter net result

$1.6B

Quarterly coverage: 53 periods · latest quarter FY2025-Q3 · TTM revenue growth 7.5%.

What this gives you

A proof-of-concept company data surface, not a dead PDF shelf.

The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.

Source audit

Official links first, raw iterFact payloads right next to them.

Official sources

SEC EDGAR companyfacts
comparative · abbott-laboratories-fy2007 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2010-02-19 · Retrieved: 2026-04-26T11:38:45.959296+00:00
SEC EDGAR companyfacts
primary · abbott-laboratories-fy2010 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2011-02-18 · Retrieved: 2026-04-26T11:38:45.959296+00:00
SEC EDGAR companyfacts
primary · abbott-laboratories-fy2011 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2012-02-21 · Retrieved: 2026-04-26T11:38:45.959296+00:00
SEC EDGAR companyfacts
us-gaap:NetIncomeLoss · us gaap companyfacts · comparative · abbott-laboratories-fy2011 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2014-02-21 · Retrieved: 2026-04-26T11:38:45.959296+00:00
SEC EDGAR companyfacts
primary · abbott-laboratories-fy2012 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2013-02-15 · Retrieved: 2026-04-26T11:38:45.959296+00:00

Ten-year series

Headline company financials by fiscal year

Fiscal year	Revenue	Adj. EBITDA	EBIT	Net result	Op. cash flow	Capex	Net debt	Status
FY2007	26B	—	5B	—	5B	-2B	10B	comparative annual fact carried from later 10k · missing adjusted ebitda · missing gross profit · missing net result · missing research and development
FY2008	30B	—	6B	—	7B	-1B	7B	comparative annual fact carried from later 10k · missing adjusted ebitda · missing gross profit · missing net result · missing research and development
FY2009	31B	—	6B	—	7B	-1B	8B	missing adjusted ebitda · missing gross profit · missing net result · missing research and development
FY2010	35B	—	6B	—	9B	-1B	15B	missing adjusted ebitda · missing gross profit · missing net result · missing research and development
FY2011	39B	—	6B	5B	9B	-1B	9B	missing adjusted ebitda · missing gross profit · missing research and development
FY2012	40B	—	8B	6B	9B	-2B	10B	missing adjusted ebitda · missing gross profit · missing research and development
FY2013	22B	—	3B	3B	3B	-1B	3B	missing adjusted ebitda · missing gross profit · missing research and development
FY2014	20B	—	3B	2B	4B	-1B	4B	missing adjusted ebitda · missing gross profit · missing research and development
FY2015	20B	—	3B	4B	3B	-1B	4B	missing adjusted ebitda · missing gross profit · missing research and development

Filing provenance